Skip to main content
Fig. 2 | Military Medical Research

Fig. 2

From: Acellular scaffold-based approach for in situ genetic engineering of host T-cells in solid tumor immunotherapy

Fig. 2

PEGDA–PLL matrix promotes more cellular infiltration. a Experimental design for cellular infiltration studies in 3D implants. b Digital micrographs of explanted implants on day 7 showing red color due to infiltration of blood vessels. c Quantification of different immune cells (CD3+, CD86+, F4/80+, CD14+, CD19+, and CD11c+ respectively) infiltrating the PEGDA and PEGDA–PLL implants on day 3 and day 7. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA with Tukey’s test. PEGDA polyethylene glycol diacrylate, PLL poly-L-lysine

Back to article page